LAF237 (linagliptin)

linagliptin · Boehringer Ingelheim and Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAF237 (linagliptin), covering 2011-03-23 to 2011-03-23. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of LAF237 on Gastric Function in Type 2 Diabetes [Phase 3]